2014.07 |
Anti-lipoapoptotic effect of Artemisia capillaris extract on free fatty acids-induced HepG2 cells |
2014.09 |
Effects of β-sitosterol derived from Artemisia capillaris on the activated human hepatic stellate cells and dimethylnitrosamine-induced mouse liver fibrosis |
2014.10 |
Anti-fibrotic effects of Kyungheechunggan-tang on activated hepatic stellate cells and rat liver |
2015.08 |
A Survey of Therapeutic Effects of Artemisia capillaris in Liver Diseases |
2015.12 |
Drug-induced liver injury: A 2-year retrospective study of 1169 hospitalized patients in a single medical center |
2017.01 |
Evaluation of antitumor activity of Artemisia capillaris extract against hepatocellular carcinoma through the inhibition of IL-6/STAT3 signaling axis |
2017.10 |
Effects of Kamichunggantang on Lipoapoptosis and inflammation of NAFLD in db/db mice |
2017.10 |
The therapeutic effects of Yongdamsagan-tang on autoimmune hepatitis models |
2017.11 |
Kyungheechunggan-Tang-01, a New Herbal Medication, Suppresses LPS-Induced Inflammatory Responses through JAK/STAT Signaling Pathway in RAW 264.7 Macrophages |
2018.02 |
Phytotherapeutic Activities of Sanguisorba officinalis and its Chemical Constituents: A Review |
2018.06 |
Sanguisorba officinalis extract, ziyuglycoside I, and II exhibit antiviral effects against hepatitis B virus |
2018.07 |
Preclinical Evaluation of In Vitro and In Vivo Antiviral Activities of KCT-01, a New Herbal Formula against Hepatitis B Virus |
2019.06 |
Pharmacological Activities of Alisma orientale against Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: Literature Review |
2020.07 |
Preclinical Evidence of Curcuma longa and Its Noncurcuminoid Constituents against Hepatobiliary Diseases: A Review |
2021.02 |
Beneficial Actions of Orostachys japonica and Its Compounds against Tumors via MAPK Signaling Pathways |
2021.07 |
Promising Anticancer Activities of Alismatis rhizome and Its Triterpenes via p38 and PI3K/Akt/mTOR Signaling Pathways |